Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

IL-17RC is required for immune signaling via an extended SEF/IL-17R signaling domain in the cytoplasmic tail.

Ho AW, Shen F, Conti HR, Patel N, Childs EE, Peterson AC, Hernández-Santos N, Kolls JK, Kane LP, Ouyang W, Gaffen SL.

J Immunol. 2010 Jul 15;185(2):1063-70. doi: 10.4049/jimmunol.0903739.

2.

SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.

Onishi RM, Park SJ, Hanel W, Ho AW, Maitra A, Gaffen SL.

J Biol Chem. 2010 Oct 22;285(43):32751-9. doi: 10.1074/jbc.M110.121418.

3.

A CC' loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation.

Liu C, Swaidani S, Qian W, Kang Z, Sun P, Han Y, Wang C, Gulen MF, Yin W, Zhang C, Fox PL, Aronica M, Hamilton TA, Misra S, Deng J, Li X.

Sci Signal. 2011 Nov 1;4(197):ra72. doi: 10.1126/scisignal.2001843.

4.

Crystal structure of IL-17 receptor B SEFIR domain.

Zhang B, Liu C, Qian W, Han Y, Li X, Deng J.

J Immunol. 2013 Mar 1;190(5):2320-6. doi: 10.4049/jimmunol.1202922. Erratum in: J Immunol. 2013 May 1;190(9):4910.

5.

IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.

Hu Y, Ota N, Peng I, Refino CJ, Danilenko DM, Caplazi P, Ouyang W.

J Immunol. 2010 Apr 15;184(8):4307-16. doi: 10.4049/jimmunol.0903614.

6.

IL-17RC: a partner in IL-17 signaling and beyond.

Ho AW, Gaffen SL.

Semin Immunopathol. 2010 Mar;32(1):33-42. doi: 10.1007/s00281-009-0185-0. Review.

7.

Structure of the unique SEFIR domain from human interleukin 17 receptor A reveals a composite ligand-binding site containing a conserved α-helix for Act1 binding and IL-17 signaling.

Zhang B, Liu C, Qian W, Han Y, Li X, Deng J.

Acta Crystallogr D Biol Crystallogr. 2014 May;70(Pt 5):1476-83. doi: 10.1107/S1399004714005227.

8.

The anaphase-promoting complex protein 5 (AnapC5) associates with A20 and inhibits IL-17-mediated signal transduction.

Ho AW, Garg AV, Monin L, Simpson-Abelson MR, Kinner L, Gaffen SL.

PLoS One. 2013 Jul 29;8(7):e70168. doi: 10.1371/journal.pone.0070168.

10.

Signaling through IL-17C/IL-17RE is dispensable for immunity to systemic, oral and cutaneous candidiasis.

Conti HR, Whibley N, Coleman BM, Garg AV, Jaycox JR, Gaffen SL.

PLoS One. 2015 Apr 7;10(4):e0122807. doi: 10.1371/journal.pone.0122807.

11.

The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease.

Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X.

Nat Immunol. 2007 Mar;8(3):247-56.

PMID:
17277779
12.

The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex.

Wright JF, Bennett F, Li B, Brooks J, Luxenberg DP, Whitters MJ, Tomkinson KN, Fitz LJ, Wolfman NM, Collins M, Dunussi-Joannopoulos K, Chatterjee-Kishore M, Carreno BM.

J Immunol. 2008 Aug 15;181(4):2799-805.

13.

Identification of the IL-17 receptor related molecule IL-17RC as the receptor for IL-17F.

Kuestner RE, Taft DW, Haran A, Brandt CS, Brender T, Lum K, Harder B, Okada S, Ostrander CD, Kreindler JL, Aujla SJ, Reardon B, Moore M, Shea P, Schreckhise R, Bukowski TR, Presnell S, Guerra-Lewis P, Parrish-Novak J, Ellsworth JL, Jaspers S, Lewis KE, Appleby M, Kolls JK, Rixon M, West JW, Gao Z, Levin SD.

J Immunol. 2007 Oct 15;179(8):5462-73.

14.

Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.

Shi P, Zhu S, Lin Y, Liu Y, Liu Y, Chen Z, Shi Y, Qian Y.

Sci Signal. 2011 Nov 1;4(197):ra73. doi: 10.1126/scisignal.2001653.

15.

Interleukin-17-induced protein lipocalin 2 is dispensable for immunity to oral candidiasis.

Ferreira MC, Whibley N, Mamo AJ, Siebenlist U, Chan YR, Gaffen SL.

Infect Immun. 2014 Mar;82(3):1030-5. doi: 10.1128/IAI.01389-13.

16.

Molecular characterization and evolution analysis of five interleukin-17 receptor genes in large yellow croaker Larimichthys crocea.

Ding Y, Ai C, Mu Y, Ao J, Chen X.

Fish Shellfish Immunol. 2016 Nov;58:332-339. doi: 10.1016/j.fsi.2016.09.017.

PMID:
27633682
17.

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.

Boisson B, Wang C, Pedergnana V, Wu L, Cypowyj S, Rybojad M, Belkadi A, Picard C, Abel L, Fieschi C, Puel A, Li X, Casanova JL.

Immunity. 2013 Oct 17;39(4):676-86. doi: 10.1016/j.immuni.2013.09.002.

18.

Act1, a U-box E3 ubiquitin ligase for IL-17 signaling.

Liu C, Qian W, Qian Y, Giltiay NV, Lu Y, Swaidani S, Misra S, Deng L, Chen ZJ, Li X.

Sci Signal. 2009 Oct 13;2(92):ra63. doi: 10.1126/scisignal.2000382. Erratum in: Sci Signal. 2010;3(121):er3.

19.

Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression.

Maitra A, Shen F, Hanel W, Mossman K, Tocker J, Swart D, Gaffen SL.

Proc Natl Acad Sci U S A. 2007 May 1;104(18):7506-11.

20.

Interleukin-17F signaling requires ubiquitination of interleukin-17 receptor via TRAF6.

Rong Z, Cheng L, Ren Y, Li Z, Li Y, Li X, Li H, Fu XY, Chang Z.

Cell Signal. 2007 Jul;19(7):1514-20.

PMID:
17346928

Supplemental Content

Support Center